Recombinant plasma protein therapeutics market is expected to grow at a significant CAGR during the forecast period. The major factors that are leading to the growth of the global recombinant plasma protein therapeutics market include the increasing prevalence of autoimmune disorders, immune deficiency disorders, neurological and bleeding disorders. Along with these factors, the rise in […]
Tag Archives: Recombinant Plasma Protein Therapeutics Market
The Global Recombinant Plasma Protein Therapeutics Market was valued at US$ 8.2 Bn in 2020. It is anticipated expand at a CAGR of 8% from 2022 to 2028. Recombinant proteins are produced by combining DNA fragments from different organisms. Recombinant proteins often come from mice, bacteria or yeast and can be used to treat human diseases. They […]